Order Tests Now

Early Cancer Detection.

Reliable Results.

Proactive screening for 60+ cancer types to help you keep living your best life.*

ORDER NOW

The EPISEEK® Test detects the most common cancers before symptoms appear.

EPISEEK screens for 60+ CANCERS—more than any other multi-cancer early detection test—and is the only one to screen for brain cancer.

A

Adrenal gland, Pheochromocytoma

B

Bile duct, Cholangiocarcinoma

Bladder, Papillary transitional cell carcinoma

Bladder, Transitional cell carcinoma

Bone marrow, Acute myeloid leukemia with maturation

Bone marrow, B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma

Bone marrow, Plasma cell myeloma

Brain, Glioblastoma

Breast, Neoplasm, malignant

Breast, Lobular carcinoma

C

Cervix, Endometrioid adenocarcinoma

Cervix, Squamous cell carcinoma

Colon, Adenocarcinoma

Colon, Signet ring cell carcinoma

Connective and soft tissue, Dedifferentiated liposarcoma

Connective and soft tissue, Malignant fibrous histiocytoma

Connective and soft tissue, Myxofibrosarcoma

Connective and soft tissue, Myxoid liposarcoma

D

Duodenum, Adenocarcinoma

E

Endometrium, Endometrioid adenocarcinoma

Endometrium, Serous carcinoma

Esophagus, G-E junction adenocarcinoma

Esophagus, Squamous cell carcinoma, large cell, nonkeratinizing

F

Fallopian tube, Serous carcinoma

H

Hematopoietic system, Diffuse large B-cell lymphoma

J

Jaw, Squamous cell carcinoma, keratinizing

K

Kidney, Clear cell adenocarcinoma

Kidney, Papillary adenocarcinoma

Kidney, Renal cell carcinoma, sarcomatoid

Kidney, Renal pelvis transitional cell carcinoma

L

Larynx, Basaloid squamous cell carcinoma

Larynx, Squamous cell carcinoma

Larynx, Squamous cell carcinoma, keratinizing

Larynx, Squamous cell carcinoma, large cell, nonkeratinizing

Lip, Squamous cell carcinoma

Lung, Acinar cell cystadenocarcinoma

Lung, Neuroendocrine tumor

Lung, Non-small cell carcinoma

Lung, Small cell carcinoma

Lung, Squamous cell carcinoma

Lung, Squamous cell carcinoma, keratinizing

Lung, Squamous cell carcinoma, large cell, nonkeratinizing

M

Mouth, Palate squamous cell carcinoma

O

Oropharynx, Squamous cell carcinoma, large cell, nonkeratinizing

Ovary, High-grade serous carcinoma

Ovary, Low-grade serous carcinoma

Ovary, Mucinous adenocarcinoma

P

Pancreas, Ampulla of Vater adenocarcinoma

Pancreas, Infiltrating duct carcinoma

Pancreas, Intraductal papillary mucinous adenoma (IPMN)

Pancreas, Pancreatic neuroendocrine tumor, nonfunctioning

Pancreas, Solid pseudopapillary carcinoma

Peritoneum, Epithelioid mesothelioma

Prostate, Neoplasm, malignant

S

Skin, Amelanotic melanoma

Skin, Nodular melanoma

Skin, Vulva squamous cell carcinoma

Stomach, Adenosquamous carcinoma

Stomach, Tubular adenocarcinoma

T

Testis, Diffuse large B-cell lymphoma

Testis, Germ cell tumor, nonseminomatous

Testis, Mixed germ cell tumor

Testis, Seminoma

Thyroid, Papillary adenocarcinoma

Tongue, Squamous cell carcinoma, large cell, nonkeratinizing

EPISEEK

The Future of Cancer Detection

EPISEEK is a cutting-edge multi-cancer early detection (MCED) test that uses a simple blood draw to identify DNA changes linked to over 60 types of cancer. By detecting hypermethylated DNA loci—i.e., regions consistently altered across multiple cancer types—EPISEEK provides reliable, early detection, even before symptoms appear.

LEARN MORE

*The EPISEEK test may not identify signals for every type of cancer at every stage. There is a possibility of false positive and false negative results.

How It Works

EPISEEK redefines cancer detection and monitoring, identifying cancer with more specificity than imaging and by being more accessible than invasive tissue biopsies.

Provider Draws Blood

Test Is Sent to Lab

Specimen Is Analyzed

Provider Explains Results

Results in Just 7–10 Days

LEARN MORE

Who Is EPISEEK For?

The EPISEEK test is recommended for the following :

Individuals at Higher Risk

  • Those with a personal or family history of cancer
  • Individuals with lifestyle or environmental exposures that increase risk (e.g., firefighters)

Health-Conscious Individuals

  • People who prioritize preventive health care and want to take proactive steps to monitor their health

Individuals Aged 45 or Older

Healthcare Providers

  • Physicians, oncologists, and general practitioners seeking advanced diagnostic tools to offer their patients
  • Clinics and hospitals that want to integrate cutting-edge cancer screening into their services

Researchers and Institutions

  • Institutions interested in leveraging innovation technologies for further studies in early cancer detection

Employers or Wellness Programs

  • Organizations aiming to enhance employee health benefits by providing access to advanced health screenings

The EPISEEK test is NOT RECOMMENDED for the following:

Individuals who are pregnant

Individuals undergoing active cancer treatment or those with an active known malignancy

Individuals aged 21 years or younger

Talk to your healthcare provider about including the EPISEEK test as part of your annual checkup!

LEARN MORE

Providers Recommend EPISEEK for Early Detection

“As a physician, I know that early detection is critical in the fight against cancer. The EPISEEK liquid biopsy test is a groundbreaking tool that identifies cancer at its earliest stages, when it’s most treatable. I highly recommend Precision Epigenomics for its accuracy and its potential to save lives by catching cancer before symptoms begin. Not only do I order EPISEEK for my patients, but my healthcare provider also ordered it for me.”

— Kristine Romine, MD

“I use EPISEEK alongside standard guideline-based cancer screenings for my patients. It offers exceptional specificity and is an excellent tool for early detection. EPISEEK screens for the top 10 leading causes of cancer-related deaths, including brain cancer, and is available at a more accessible price point than alternatives. It’s a great choice for my patients to help with early detection of cancer.”

— Carl Seger, MD

“When I received my EPISEEK results showing no cancer signals, it felt like a weight had been lifted. Adding this test to my regular screenings gives me confidence that I’m doing everything I can to protect my health. That peace of mind is priceless. I encourage anyone thinking about additional screening to take that step—you won’t regret it.”

— Lissa Druss

Recent Articles